Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Irwin

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The International Journal of Biochemistry & Cell Biology|August 21, 2012
Mouse models of mitochondrial complex I dysfunctionMichael H Irwin, Kodeeswaran Parameshwaran, Carl A Pinkert
Drug Development Research|April 8, 2015
Mitochondrially-imported RNA in drug discoveryMatthew V Cannon, Michael H Irwin, Carl A Pinkert
Pharmacology, Biochemistry, and Behavior|February 28, 2012
Protection by an antioxidant of rotenone-induced neuromotor decline, reactive oxygen species generation and cellular stress in mouse brainKodeeswaran Parameshwaran, Michael H Irwin, Kosta Steliou, et al.
Rejuvenation Research|January 6, 2011
D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in miceKodeeswaran Parameshwaran, Michael H Irwin, Kosta Steliou, et al.
Biochimica Et Biophysica Acta|August 23, 2011
Animal models of human mitochondrial DNA mutationsDavid A Dunn, Matthew V Cannon, Michael H Irwin, et al.
Drug Development Research|April 8, 2015
Antioxidant-mediated reversal of oxidative damage in mouse modeling of complex I inhibitionKodeeswaran Parameshwaran, Michael H Irwin, Kosta Steliou, et al.
Drug Development Research|June 26, 2015
Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of ageKosta Steliou, Douglas V Faller, Carl A Pinkert, et al.
Drug Development Research|February 23, 2016
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson DiseasesMichael H Irwin, Walter H Moos, Douglas V Faller, et al.
Drug Development Research|October 21, 2016
Epigenetic Treatment of Persistent Viral InfectionsWalter H Moos, Carl A Pinkert, Michael H Irwin, et al.
Drug Development Research|February 23, 2016
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and SchizophreniaWalter H Moos, Eleni Maneta, Carl A Pinkert, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The International Journal of Biochemistry & Cell Biology|August 21, 2012
Mouse models of mitochondrial complex I dysfunctionMichael H Irwin, Kodeeswaran Parameshwaran, Carl A Pinkert
Drug Development Research|April 8, 2015
Mitochondrially-imported RNA in drug discoveryMatthew V Cannon, Michael H Irwin, Carl A Pinkert
Pharmacology, Biochemistry, and Behavior|February 28, 2012
Protection by an antioxidant of rotenone-induced neuromotor decline, reactive oxygen species generation and cellular stress in mouse brainKodeeswaran Parameshwaran, Michael H Irwin, Kosta Steliou, et al.
Rejuvenation Research|January 6, 2011
D-galactose effectiveness in modeling aging and therapeutic antioxidant treatment in miceKodeeswaran Parameshwaran, Michael H Irwin, Kosta Steliou, et al.
Biochimica Et Biophysica Acta|August 23, 2011
Animal models of human mitochondrial DNA mutationsDavid A Dunn, Matthew V Cannon, Michael H Irwin, et al.
Drug Development Research|April 8, 2015
Antioxidant-mediated reversal of oxidative damage in mouse modeling of complex I inhibitionKodeeswaran Parameshwaran, Michael H Irwin, Kosta Steliou, et al.
Drug Development Research|June 26, 2015
Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of ageKosta Steliou, Douglas V Faller, Carl A Pinkert, et al.
Drug Development Research|February 23, 2016
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson DiseasesMichael H Irwin, Walter H Moos, Douglas V Faller, et al.
Drug Development Research|October 21, 2016
Epigenetic Treatment of Persistent Viral InfectionsWalter H Moos, Carl A Pinkert, Michael H Irwin, et al.
Drug Development Research|February 23, 2016
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and SchizophreniaWalter H Moos, Eleni Maneta, Carl A Pinkert, et al.
Pageof 2